Breaking News Instant updates and real-time market news.

AEE

Ameren

$83.61 /

-1.2 (-1.41%)

07:31
02/26/20
02/26
07:31
02/26/20
07:31

Ameren reports Q4 EPS 38c, consensus 31c

Reports Q4 revenue $1.32B, consensus $1.64B.

  • 26

    Feb

  • 02

    Mar

AEE Ameren
$83.61 /

-1.2 (-1.41%)

02/19/20 BMO Capital
Ameren initiated with an Outperform at BMO Capital
02/14/20 Wells Fargo
Ameren price target raised to $95 from $86 at Wells Fargo
02/03/20 JPMorgan
Evergy price target raised to $76 from $72 at JPMorgan
01/29/20 Morgan Stanley
Ameren upgraded to Overweight on renewables opportunity at Morgan Stanley

TODAY'S FREE FLY STORIES

Upgrade
Benchmark Holdings upgraded to Buy from Hold at Kepler Cheuvreux » 05:18
03/02/21
03/02
05:18
03/02/21
05:18
BHCCF

Benchmark Holdings

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHCCF Benchmark Holdings
$0.00 /

+ (+0.00%)

01/07/21 Pareto
Benchmark Holdings downgraded to Hold from Buy at Pareto
Upgrade
Cargojet upgraded to Outperform from Sector Perform at Scotiabank » 05:17
03/02/21
03/02
05:17
03/02/21
05:17
CGJTF

Cargojet

$0.00 /

+ (+0.00%)

Scotiabank analyst Konark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGJTF Cargojet
$0.00 /

+ (+0.00%)

CGJTF Cargojet
$0.00 /

+ (+0.00%)

02/02/21 RBC Capital
Cargojet price target raised to C$315 from C$310 at RBC Capital
02/02/21 BMO Capital
Cargojet price target raised to C$270 from C$265 at BMO Capital
02/02/21 Scotiabank
Cargojet price target raised to C$240 from C$230 at Scotiabank
02/02/21 National Bank
Cargojet resumed with an Outperform at National Bank
CGJTF Cargojet
$0.00 /

+ (+0.00%)

Upgrade
Tim SA upgraded to Sector Perform from Underperform at Scotiabank » 05:17
03/02/21
03/02
05:17
03/02/21
05:17
TIMB

Tim SA

$11.30 /

-0.17 (-1.48%)

Scotiabank analyst Andres…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TIMB Tim SA
$11.30 /

-0.17 (-1.48%)

TIMB Tim SA
$11.30 /

-0.17 (-1.48%)

11/26/20 New Street
Tim SA initiated with a Buy at New Street
Hot Stocks
Elbit Systems awarded $300M contract to provide Hermes 900 to country in Asia » 05:15
03/02/21
03/02
05:15
03/02/21
05:15
ESLT

Elbit Systems

$133.20 /

+5.59 (+4.38%)

Elbit Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESLT Elbit Systems
$133.20 /

+5.59 (+4.38%)

ESLT Elbit Systems
$133.20 /

+5.59 (+4.38%)

11/18/20 Jefferies
Elbit Systems downgraded to Hold on defense slowdown at Jefferies
11/18/20 Jefferies
Elbit Systems downgraded to Hold from Buy at Jefferies
Hot Stocks
Motorola Solutions awarded contract by HDO HF for CRS » 05:12
03/02/21
03/02
05:12
03/02/21
05:12
MSI

Motorola Solutions

$182.21 /

+6.28 (+3.57%)

Motorola Solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSI Motorola Solutions
$182.21 /

+6.28 (+3.57%)

MSI Motorola Solutions
$182.21 /

+6.28 (+3.57%)

02/05/21 Cowen
Motorola Solutions price target raised to $216 from $183 at Cowen
02/05/21 Barclays
Motorola Solutions price target raised to $206 from $196 at Barclays
02/05/21 Citi
Motorola Solutions price target raised to $210 from $190 at Citi
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
MSI Motorola Solutions
$182.21 /

+6.28 (+3.57%)

MSI Motorola Solutions
$182.21 /

+6.28 (+3.57%)

MSI Motorola Solutions
$182.21 /

+6.28 (+3.57%)

Initiation
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs » 05:11
03/02/21
03/02
05:11
03/02/21
05:11
TERN

Terns Pharmaceuticals

$24.21 /

+1.38 (+6.04%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 05
    Feb
TERN Terns Pharmaceuticals
$24.21 /

+1.38 (+6.04%)

Recommendations
uniQure price target raised to $100 from $85 at Chardan » 05:09
03/02/21
03/02
05:09
03/02/21
05:09
QURE

uniQure

$38.03 /

+1.39 (+3.79%)

Chardan analyst Gbola…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$38.03 /

+1.39 (+3.79%)

QURE uniQure
$38.03 /

+1.39 (+3.79%)

12/22/20 Chardan
uniQure selloff on clinical hold brings good entry point, says Chardan
12/22/20 Jefferies
uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies
12/22/20 RBC Capital
uniQure price target lowered to $53 from $61 at RBC Capital
12/22/20 H.C. Wainwright
uniQure price target lowered to $80 from $85 at H.C. Wainwright
QURE uniQure
$38.03 /

+1.39 (+3.79%)

QURE uniQure
$38.03 /

+1.39 (+3.79%)

Hot Stocks
G. Willi-Food CEO Einat Shapira to resign » 05:09
03/02/21
03/02
05:09
03/02/21
05:09
WILC

G. Willi-Food

$24.48 /

+0.47 (+1.96%)

G. Willi-Food announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Piper lowers Inovio target to $7 after 'decidedly negative' update » 05:08
03/02/21
03/02
05:08
03/02/21
05:08
INO

Inovio

$11.64 /

+0.52 (+4.68%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INO Inovio
$11.64 /

+0.52 (+4.68%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
01/08/21 Benchmark
Inovio price target lowered to $15 from $25 at Benchmark
INO Inovio
$11.64 /

+0.52 (+4.68%)

  • 21
    Jan
INO Inovio
$11.64 /

+0.52 (+4.68%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

INO Inovio
$11.64 /

+0.52 (+4.68%)

Hot Stocks
Motional selects Ambarella CVflow AI processors for driverless vehicles » 05:06
03/02/21
03/02
05:06
03/02/21
05:06
AMBA

Ambarella

$118.61 /

+6.12 (+5.44%)

Ambarella announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$118.61 /

+6.12 (+5.44%)

AMBA Ambarella
$118.61 /

+6.12 (+5.44%)

02/24/21 Deutsche Bank
Ambarella price target raised to $100 from $75 at Deutsche Bank
01/21/21 Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
01/13/21 Roth Capital
Ambarella upgraded to Buy from Neutral at Roth Capital
AMBA Ambarella
$118.61 /

+6.12 (+5.44%)

AMBA Ambarella
$118.61 /

+6.12 (+5.44%)

AMBA Ambarella
$118.61 /

+6.12 (+5.44%)

Recommendations
Sarepta price target lowered to $130 from $140 at Piper Sandler » 05:05
03/02/21
03/02
05:05
03/02/21
05:05
SRPT

Sarepta

$86.94 /

-0.07 (-0.08%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

02/26/21 Mizuho
Sarepta price target raised to $160 from $158 at Mizuho
02/25/21 Piper Sandler
Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

SRPT Sarepta
$86.94 /

-0.07 (-0.08%)

Initiation
Immunocore initiated with a Neutral at Goldman Sachs » 05:04
03/02/21
03/02
05:04
03/02/21
05:04
IMCR

Immunocore

$50.10 /

+2.77 (+5.85%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMCR Immunocore
$50.10 /

+2.77 (+5.85%)

  • 05
    Feb
IMCR Immunocore
$50.10 /

+2.77 (+5.85%)

Recommendations
Dicerna price target raised to $34 from $25 at Chardan » 05:04
03/02/21
03/02
05:04
03/02/21
05:04
DRNA

Dicerna

$28.88 /

+1.86 (+6.88%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

03/01/21 B. Riley Securities
Dicerna price target raised to $40 from $37 at B. Riley Securities
01/11/21 B. Riley Securities
Dicerna price target raised to $37 from $30 at B. Riley Securities
08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

Downgrade
Brasileira de Distribuicao downgraded to Neutral from Buy at Goldman Sachs » 05:00
03/02/21
03/02
05:00
03/02/21
05:00
CBD

Companhia Brasileira de Distribuicao

$16.49 /

+1.515 (+10.12%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBD Companhia Brasileira de Distribuicao
$16.49 /

+1.515 (+10.12%)

Initiation
Vor Biopharma initiated with a Sell at Goldman Sachs » 04:59
03/02/21
03/02
04:59
03/02/21
04:59
VOR

Vor Biopharma

$48.00 /

+3.06 (+6.81%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VOR Vor Biopharma
$48.00 /

+3.06 (+6.81%)

VOR Vor Biopharma
$48.00 /

+3.06 (+6.81%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
  • 05
    Feb
VOR Vor Biopharma
$48.00 /

+3.06 (+6.81%)

Initiation
Gemini Therapeutics initiated with a Buy at Goldman Sachs » 04:56
03/02/21
03/02
04:56
03/02/21
04:56
GMTX

Gemini Therapeutics

$15.60 /

+0.44 (+2.90%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMTX Gemini Therapeutics
$15.60 /

+0.44 (+2.90%)

GMTX Gemini Therapeutics
$15.60 /

+0.44 (+2.90%)

02/16/21 Stifel
Gemini Therapeutics initiated with a Buy at Stifel
GMTX Gemini Therapeutics
$15.60 /

+0.44 (+2.90%)

Recommendations
Align Technology pullback brings attractive entry point, says Piper Sandler » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
ALGN

Align Technology

$565.06 /

-4.05 (-0.71%)

Shares of Align…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGN Align Technology
$565.06 /

-4.05 (-0.71%)

ALGN Align Technology
$565.06 /

-4.05 (-0.71%)

02/04/21 Evercore ISI
Align Technology price target raised to $680 from $625 at Evercore ISI
02/04/21 Credit Suisse
Align Technology price target raised to $630 from $618 at Credit Suisse
02/04/21 Barclays
Align Technology price target raised to $555 from $475 at Barclays
02/04/21 Piper Sandler
Align Technology price target raised to $700 from $610 at Piper Sandler
ALGN Align Technology
$565.06 /

-4.05 (-0.71%)

ALGN Align Technology
$565.06 /

-4.05 (-0.71%)

ALGN Align Technology
$565.06 /

-4.05 (-0.71%)

Conference/Events
The Genome Partnership to hold a virtual meeting » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
NSTG

NanoString

$74.48 /

+4.46 (+6.37%)

, TWST

Twist Bioscience

$145.03 /

+7.29 (+5.29%)

, PACB

Pacific Biosciences

$35.25 /

+4.68 (+15.31%)

, QGEN

Qiagen

$50.35 /

+0.3 (+0.60%)

, TXG

10x Genomics

$186.79 /

+8.82 (+4.96%)

, CDXS

Codexis

$23.48 /

+1.3 (+5.86%)

, PKI

PerkinElmer

$129.77 /

+3.58 (+2.84%)

, ILMN

Illumina

$446.26 /

+6.68 (+1.52%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BNGO

Bionano Genomics

$9.84 /

+0.105 (+1.08%)

Advances in Genome…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 7 minutes

Get Free Trial

ShowHide Related Items >><<
NSTG NanoString
$74.48 /

+4.46 (+6.37%)

TWST Twist Bioscience
$145.03 /

+7.29 (+5.29%)

PACB Pacific Biosciences
$35.25 /

+4.68 (+15.31%)

QGEN Qiagen
$50.35 /

+0.3 (+0.60%)

TXG 10x Genomics
$186.79 /

+8.82 (+4.96%)

CDXS Codexis
$23.48 /

+1.3 (+5.86%)

PKI PerkinElmer
$129.77 /

+3.58 (+2.84%)

ILMN Illumina
$446.26 /

+6.68 (+1.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BNGO Bionano Genomics
$9.84 /

+0.105 (+1.08%)

NSTG NanoString
$74.48 /

+4.46 (+6.37%)

01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
01/06/21 Cowen
NanoString upgraded to Outperform from Market Perform at Cowen
12/02/20 JPMorgan
NanoString price target raised to $60 from $45 at JPMorgan
TWST Twist Bioscience
$145.03 /

+7.29 (+5.29%)

02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
02/05/21 JPMorgan
Twist Bioscience downgraded to Underweight from Neutral at JPMorgan
01/04/21 Evercore ISI
Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time
01/04/21 Evercore ISI
Twist Bioscience downgraded to In Line from Outperform at Evercore ISI
PACB Pacific Biosciences
$35.25 /

+4.68 (+15.31%)

02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
01/12/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $45 from $25 at Cantor Fitzgerald
QGEN Qiagen
$50.35 /

+0.3 (+0.60%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
TXG 10x Genomics
$186.79 /

+8.82 (+4.96%)

02/18/21 Cowen
10x Genomics price target raised to $200 from $155 at Cowen
02/18/21 JPMorgan
10x Genomics price target raised to $195 from $160 at JPMorgan
02/18/21 Citi
10x Genomics price target raised to $240 from $195 at Citi
12/16/20 Citi
10x Genomics price target raised to $195 from $165 at Citi
CDXS Codexis
$23.48 /

+1.3 (+5.86%)

03/01/21 Stifel
Codexis initiated with a Buy at Stifel
12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
PKI PerkinElmer
$129.77 /

+3.58 (+2.84%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
ILMN Illumina
$446.26 /

+6.68 (+1.52%)

02/16/21 BTIG
Illumina price target raised to $570 from $410 at BTIG
02/12/21 Piper Sandler
Illumina price target raised to $510 from $415 at Piper Sandler
02/12/21 Cowen
Illumina price target raised to $460 from $385 at Cowen
12/22/20
Fly Intel: Top five analyst upgrades
RHHBY Roche
$0.00 /

+ (+0.00%)

02/25/21 Berenberg
Roche price target lowered to CHF 320 from CHF 325 at Berenberg
02/24/21 Morgan Stanley
Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/17/21 UBS
UBS downgrades Roche to Neutral on risk to 2022 estimates
BNGO Bionano Genomics
$9.84 /

+0.105 (+1.08%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
NSTG NanoString
$74.48 /

+4.46 (+6.37%)

TWST Twist Bioscience
$145.03 /

+7.29 (+5.29%)

PACB Pacific Biosciences
$35.25 /

+4.68 (+15.31%)

QGEN Qiagen
$50.35 /

+0.3 (+0.60%)

TXG 10x Genomics
$186.79 /

+8.82 (+4.96%)

CDXS Codexis
$23.48 /

+1.3 (+5.86%)

PKI PerkinElmer
$129.77 /

+3.58 (+2.84%)

ILMN Illumina
$446.26 /

+6.68 (+1.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BNGO Bionano Genomics
$9.84 /

+0.105 (+1.08%)

  • 20
    Jan
  • 08
    Jan
  • 03
    Dec
  • 03
    Dec
  • 11
    Nov
  • 08
    Oct
  • 11
    Sep
  • 12
    Aug
  • 04
    Jun
PACB Pacific Biosciences
$35.25 /

+4.68 (+15.31%)

QGEN Qiagen
$50.35 /

+0.3 (+0.60%)

ILMN Illumina
$446.26 /

+6.68 (+1.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NSTG NanoString
$74.48 /

+4.46 (+6.37%)

TWST Twist Bioscience
$145.03 /

+7.29 (+5.29%)

PACB Pacific Biosciences
$35.25 /

+4.68 (+15.31%)

QGEN Qiagen
$50.35 /

+0.3 (+0.60%)

TXG 10x Genomics
$186.79 /

+8.82 (+4.96%)

CDXS Codexis
$23.48 /

+1.3 (+5.86%)

PKI PerkinElmer
$129.77 /

+3.58 (+2.84%)

ILMN Illumina
$446.26 /

+6.68 (+1.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BNGO Bionano Genomics
$9.84 /

+0.105 (+1.08%)

PACB Pacific Biosciences
$35.25 /

+4.68 (+15.31%)

QGEN Qiagen
$50.35 /

+0.3 (+0.60%)

PKI PerkinElmer
$129.77 /

+3.58 (+2.84%)

ILMN Illumina
$446.26 /

+6.68 (+1.52%)

BNGO Bionano Genomics
$9.84 /

+0.105 (+1.08%)

Conference/Events
Raymond James to hold a virtual conference » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
JLL

Jones Lang LaSalle

$179.05 /

+4.565 (+2.62%)

, PODD

Insulet

$270.70 /

+10.41 (+4.00%)

, SMG

Scotts Miracle-Gro

$224.83 /

+11.37 (+5.33%)

, IDXX

Idexx Laboratories

$538.76 /

+18.79 (+3.61%)

, APLS

Apellis

$47.66 /

-0.66 (-1.37%)

, AVT

Avnet

$39.47 /

+1.325 (+3.47%)

, SBAC

SBA Communications

$248.08 /

-7.18 (-2.81%)

, LPTX

Leap Therapeutics

$2.42 /

+0.06 (+2.54%)

, RJF

Raymond James

$120.98 /

+4.28 (+3.67%)

, WY

Weyerhaeuser

$35.06 /

+1.18 (+3.48%)

, LZB

La-Z-Boy

$42.00 /

-0.74 (-1.73%)

, DXCM

DexCom

$397.08 /

-2.17 (-0.54%)

, ADMA

ADMA Biologics

$2.41 /

+0.095 (+4.11%)

, CTT

CatchMark Timber

$10.59 /

+0.39 (+3.82%)

, CACI

CACI

$226.70 /

+5.55 (+2.51%)

, BR

Broadridge

$146.44 /

+3.88 (+2.72%)

, CWST

Casella Waste

$60.56 /

+2.42 (+4.16%)

, FLXN

Flexion

$11.41 /

+0.36 (+3.26%)

, HOLX

Hologic

$74.61 /

+2.46 (+3.41%)

, VSAT

ViaSat

$52.85 /

+1.34 (+2.60%)

42nd Annual Institutional…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$179.05 /

+4.565 (+2.62%)

PODD Insulet
$270.70 /

+10.41 (+4.00%)

SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

APLS Apellis
$47.66 /

-0.66 (-1.37%)

AVT Avnet
$39.47 /

+1.325 (+3.47%)

SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

LPTX Leap Therapeutics
$2.42 /

+0.06 (+2.54%)

RJF Raymond James
$120.98 /

+4.28 (+3.67%)

WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

DXCM DexCom
$397.08 /

-2.17 (-0.54%)

ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

CACI CACI
$226.70 /

+5.55 (+2.51%)

BR Broadridge
$146.44 /

+3.88 (+2.72%)

CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

FLXN Flexion
$11.41 /

+0.36 (+3.26%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

JLL Jones Lang LaSalle
$179.05 /

+4.565 (+2.62%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
PODD Insulet
$270.70 /

+10.41 (+4.00%)

02/25/21 Oppenheimer
Insulet price target raised to $277 from $235 at Oppenheimer
02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

02/04/21 Truist
Scotts Miracle-Gro price target raised to $270 from $250 at Truist
01/11/21 Raymond James
Scotts Miracle-Gro price target raised to $274 from $224 at Raymond James
01/07/21 Truist
Scotts Miracle-Gro price target raised to $250 from $180 at Truist
12/11/20
Fly Intel: Top five analyst upgrades
IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
APLS Apellis
$47.66 /

-0.66 (-1.37%)

01/29/21 Baird
Apellis assumed at Outperform at Baird
12/14/20 Roth Capital
Apellis price target raised to $73 from $50 at Roth Capital
12/10/20 Cowen
Apellis price target raised to $55 from $45 at Cowen
12/04/20 JPMorgan
Apellis price target raised to $87 from $50 at JPMorgan
AVT Avnet
$39.47 /

+1.325 (+3.47%)

02/23/21 Citi
Citi opens long Arrow Electronics, short Avnet pair trade
01/29/21 Loop Capital
Avnet price target raised to $39 from $32 at Loop Capital
01/19/21 Citi
Citi boosts Avnet target to $40, opens 'Positive Catalyst Watch'
12/14/20 Goldman Sachs
Avnet price target raised to $25 from $23 at Goldman Sachs
SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

02/23/21 Credit Suisse
SBA Communications price target lowered to $277 from $291 at Credit Suisse
02/23/21 Barclays
SBA Communications price target raised to $310 from $305 at Barclays
02/23/21 Deutsche Bank
SBA Communications price target lowered to $325 from $335 at Deutsche Bank
02/08/21 JPMorgan
JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance
LPTX Leap Therapeutics
$2.42 /

+0.06 (+2.54%)

01/29/21 Baird
Leap Therapeutics assumed at Outperform at Baird
06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
RJF Raymond James
$120.98 /

+4.28 (+3.67%)

01/29/21 Citi
Citi opens 'Positive Catalyst Watch' on Raymond James, ups price target
01/15/21 Wells Fargo
Raymond James double upgraded to Overweight at Wells Fargo
01/15/21 Wells Fargo
Raymond James upgraded to Overweight from Underweight at Wells Fargo
01/05/21 Wolfe Research
Raymond James upgraded to Outperform from Peer Perform at Wolfe Research
WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

02/01/21 DA Davidson
Weyerhaeuser price target raised to $34 from $29 at DA Davidson
12/04/20 Raymond James
Weyerhaeuser upgraded to Outperform from Market Perform at Raymond James
08/03/20
Fly Intel: Top five analyst downgrades
08/03/20 DA Davidson
Weyerhaeuser downgraded to Neutral from Buy at DA Davidson
LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
10/19/20 Sidoti
La-Z-Boy upgraded to Buy from Neutral at Sidoti
06/25/20 Stifel
La-Z-Boy price target raised to $37 from $25 at Stifel
04/13/20 Sidoti
La-Z-Boy downgraded to Neutral from Buy at Sidoti
DXCM DexCom
$397.08 /

-2.17 (-0.54%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

10/01/20 Raymond James
ADMA Biologics price target raised to $9 from $7 at Raymond James
09/30/20 Jefferies
ADMA Biologics shares 'in arbitrage territory,' says Jefferies
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/07/20 Oppenheimer
ADMA Biologics price target lowered to $7 from $14 at Oppenheimer
CTT CatchMark Timber
$10.59 /

+0.39 (+3.82%)

02/16/21 B. Riley Securities
CatchMark Timber price target raised to $12.50 from $11 at B. Riley
02/12/21 RBC Capital
CatchMark Timber cut to Sector Perform at RBC Capital on more limited growth
02/12/21 RBC Capital
CatchMark Timber downgraded to Sector Perform from Outperform at RBC Capital
10/30/20 RBC Capital
CatchMark Timber upgraded to Outperform from Sector Perform at RBC Capital
CACI CACI
$226.70 /

+5.55 (+2.51%)

02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
01/27/21 Stifel
CACI 'very likely' to bid on Perspecta as well, says Stifel
09/22/20 JPMorgan
JPMorgan upgrades 'relatively resilient' CACI to Overweight
BR Broadridge
$146.44 /

+3.88 (+2.72%)

02/03/21 BTIG
Broadridge upgraded to Buy from Neutral at BTIG
12/18/20 Truist
Broadridge initiated with a Buy at Truist
12/18/20 Truist
Broadridge initiated with a Buy at Truist
08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan
CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

12/21/20
Fly Intel: Top five analyst initiations
12/21/20 BofA
Casella Waste initiated with a Neutral at BofA
10/15/20 Berenberg
Casella Waste initiated with a Buy at Berenberg
09/24/20 Stifel
Casella Waste upgraded to Buy at Stifel, in a position to sustain 7%-8% growth
FLXN Flexion
$11.41 /

+0.36 (+3.26%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
HOLX Hologic
$74.61 /

+2.46 (+3.41%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

02/12/21 Barclays
ViaSat price target raised to $65 from $53 at Barclays
02/05/21 William Blair
William Blair upgrades ViaSat, sees upside to $90-$110 per share
02/05/21 William Blair
ViaSat upgraded to Outperform from Market Perform at William Blair
01/07/21 William Blair
ViaSat win at Delta likely brings large upfront cost, says William Blair
JLL Jones Lang LaSalle
$179.05 /

+4.565 (+2.62%)

PODD Insulet
$270.70 /

+10.41 (+4.00%)

SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

APLS Apellis
$47.66 /

-0.66 (-1.37%)

AVT Avnet
$39.47 /

+1.325 (+3.47%)

SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

LPTX Leap Therapeutics
$2.42 /

+0.06 (+2.54%)

RJF Raymond James
$120.98 /

+4.28 (+3.67%)

WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

DXCM DexCom
$397.08 /

-2.17 (-0.54%)

ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

CTT CatchMark Timber
$10.59 /

+0.39 (+3.82%)

CACI CACI
$226.70 /

+5.55 (+2.51%)

BR Broadridge
$146.44 /

+3.88 (+2.72%)

CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

FLXN Flexion
$11.41 /

+0.36 (+3.26%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

  • 21
    Oct
  • 18
    Jun
  • 21
    May
  • 13
    May
SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

SBAC SBA Communications
$248.08 /

-7.18 (-2.81%)

RJF Raymond James
$120.98 /

+4.28 (+3.67%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

SMG Scotts Miracle-Gro
$224.83 /

+11.37 (+5.33%)

APLS Apellis
$47.66 /

-0.66 (-1.37%)

LZB La-Z-Boy
$42.00 /

-0.74 (-1.73%)

DXCM DexCom
$397.08 /

-2.17 (-0.54%)

CWST Casella Waste
$60.56 /

+2.42 (+4.16%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

VSAT ViaSat
$52.85 /

+1.34 (+2.60%)

IDXX Idexx Laboratories
$538.76 /

+18.79 (+3.61%)

WY Weyerhaeuser
$35.06 /

+1.18 (+3.48%)

ADMA ADMA Biologics
$2.41 /

+0.095 (+4.11%)

HOLX Hologic
$74.61 /

+2.46 (+3.41%)

Conference/Events
Vaxart to host conference call » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
VXRT

Vaxart

$7.55 /

+0.38 (+5.30%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VXRT Vaxart
$7.55 /

+0.38 (+5.30%)

VXRT Vaxart
$7.55 /

+0.38 (+5.30%)

11/18/20 B. Riley Securities
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley Securities
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
08/12/20 H.C. Wainwright
Vaxart price target raised to $17 from $7 at H.C. Wainwright
VXRT Vaxart
$7.55 /

+0.38 (+5.30%)

VXRT Vaxart
$7.55 /

+0.38 (+5.30%)

VXRT Vaxart
$7.55 /

+0.38 (+5.30%)

Conference/Events
Cogent Communications to participate in a conference call with Cowen » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
CCOI

Cogent

$60.25 /

-0.02 (-0.03%)

Communications Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCOI Cogent
$60.25 /

-0.02 (-0.03%)

CCOI Cogent
$60.25 /

-0.02 (-0.03%)

02/03/21 MoffettNathanson
Cogent upgraded to Buy on reopening and recovery at MoffettNathanson
02/03/21 MoffettNathanson
Cogent upgraded to Buy from Neutral at MoffettNathanson
11/17/20 RBC Capital
Cogent price target lowered to $70 from $79 at RBC Capital
11/04/20 Citi
Cogent price target lowered to $75 from $89 at Citi
CCOI Cogent
$60.25 /

-0.02 (-0.03%)

Conference/Events
Morgan Stanley to hold a virtual conference » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
CEQP

Crestwood Equity

$23.08 /

+1.09 (+4.96%)

, EPD

Enterprise Products

$22.37 /

+1.045 (+4.90%)

, SEDG

SolarEdge

$307.87 /

+8.87 (+2.97%)

, PNW

Pinnacle West

$72.32 /

+2.37 (+3.39%)

Energy & Power…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
EPD Enterprise Products
$22.37 /

+1.045 (+4.90%)

SEDG SolarEdge
$307.87 /

+8.87 (+2.97%)

PNW Pinnacle West
$72.32 /

+2.37 (+3.39%)

CEQP Crestwood Equity
$23.08 /

+1.09 (+4.96%)

02/26/21 Wells Fargo
Crestwood Equity upgraded at Wells Fargo on 'solid' 2021 outlook
02/26/21 Wells Fargo
Crestwood Equity upgraded to Equal Weight from Underweight at Wells Fargo
02/16/21 Truist
Crestwood Equity upgraded to Buy from Hold at Truist
02/16/21 Truist
Crestwood Equity upgraded to Buy from Hold at Truist
EPD Enterprise Products
$22.37 /

+1.045 (+4.90%)

01/20/21 Mizuho
Enterprise Products price target raised to $27 from $24 at Mizuho
12/03/20 SMBC Nikko
Enterprise Products initiated with an Outperform at SMBC Nikko
11/23/20 Wolfe Research
Enterprise Products upgraded to Outperform from Peer Perform at Wolfe Research
11/13/20 Evercore ISI
Enterprise Products upgraded to Outperform from In Line at Evercore ISI
SEDG SolarEdge
$307.87 /

+8.87 (+2.97%)

02/18/21 Canaccord
SED International price target raised to $350 from $200 at Canaccord
02/17/21 Northland
SolarEdge price target raised to $210 from $195 at Northland
02/17/21 Roth Capital
SolarEdge price target raised to $380 from $340 at Roth Capital
02/17/21 B. Riley Securities
SolarEdge price target raised to $371 from $367 at B. Riley Securities
PNW Pinnacle West
$72.32 /

+2.37 (+3.39%)

02/25/21 Credit Suisse
Pinnacle West downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Credit Suisse
Pinnacle West price target lowered to $86 from $92 at Credit Suisse
01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
11/18/20 Barclays
Pinnacle West price target raised to $103 from $89 at Barclays
CEQP Crestwood Equity
$23.08 /

+1.09 (+4.96%)

EPD Enterprise Products
$22.37 /

+1.045 (+4.90%)

SEDG SolarEdge
$307.87 /

+8.87 (+2.97%)

PNW Pinnacle West
$72.32 /

+2.37 (+3.39%)

PNW Pinnacle West
$72.32 /

+2.37 (+3.39%)

SEDG SolarEdge
$307.87 /

+8.87 (+2.97%)

PNW Pinnacle West
$72.32 /

+2.37 (+3.39%)

EPD Enterprise Products
$22.37 /

+1.045 (+4.90%)

SEDG SolarEdge
$307.87 /

+8.87 (+2.97%)

Conference/Events
Kadant management to meet virtually with Barrington » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
KAI

Kadant

$180.50 /

+5.45 (+3.11%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KAI Kadant
$180.50 /

+5.45 (+3.11%)

KAI Kadant
$180.50 /

+5.45 (+3.11%)

02/19/21 DA Davidson
Kadant price target raised to $140 from $115 at DA Davidson
02/19/21 Barrington
Kadant upgraded to Outperform from Market Perform at Barrington
07/27/20 DA Davidson
Kadant price target raised to $105 from $75 at DA Davidson
05/28/20 Barrington
Kadant downgraded to Market Perform from Outperform at Barrington
KAI Kadant
$180.50 /

+5.45 (+3.11%)

Conference/Events
Casper Sleep management to meet virtually with Wedbush » 04:55
03/02/21
03/02
04:55
03/02/21
04:55
CSPR

Casper Sleep

$9.13 /

+0.74 (+8.82%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSPR Casper Sleep
$9.13 /

+0.74 (+8.82%)

CSPR Casper Sleep
$9.13 /

+0.74 (+8.82%)

02/25/21 Citi
Casper Sleep price target raised to $12 from $10 at Citi
11/17/20
Fly Intel: Top five analyst downgrades
11/17/20 Morgan Stanley
Casper Sleep price target lowered to $6 from $8 at Morgan Stanley
11/17/20 Goldman Sachs
Casper Sleep downgraded to Neutral from Buy at Goldman Sachs
CSPR Casper Sleep
$9.13 /

+0.74 (+8.82%)

CSPR Casper Sleep
$9.13 /

+0.74 (+8.82%)

General news
8-Week Bill Announcement to be released at 11:00  04:55
03/02/21
03/02
04:55
03/02/21
04:55
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.